Elk Creek Partners, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Elk Creek Partners, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2020$4,741,000
-20.9%
745,486
+29.7%
0.81%
+18.1%
Q4 2019$5,990,000
-50.4%
574,616
-81.3%
0.69%
-33.7%
Q3 2019$12,079,000
-20.9%
3,073,550
+199.3%
1.04%
-8.9%
Q2 2019$15,271,000
+22.6%
1,026,975
+104.7%
1.14%
+27.1%
Q1 2019$12,453,000
+82.4%
501,724
+32.0%
0.90%
+58.4%
Q4 2018$6,828,000380,1730.57%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders